LECT2 and metabolic dysfunction-associated steatohepatitis: LECT2, first identified as a chemokine for neutrophil migration (58, 59) is associated with immune diseases like non-alcoholic steatohepatitis (NASH), atherosclerosis (AS) (27) and cholestatic liver disease.